Adam Mence, Senior Brand Manager at L&R Medical UK, discusses the challenges of lower limb wound management and the benefits of driving evidence-based and self-care interventions.
A new tool designed to help healthcare professionals boost diabetes referrals to structured education courses is being announced by Diabetes UK and Kent and Medway STP.
The new measures include a working group for learning disabilities and autism and funding specialist advocates to review the care of patients in segregation or long-term seclusion.
Numbers have reached record highs with over 870,000 clinical trial participants involved in research studies supported by the National Institute for Health Research (NIHR) over the last year.
According to the Alzheimer Society 850,000 people in the UK have dementia but with 1 in 6 people over the age of 80 living with dementia, this is predicted to rise to over 2 million by 2050 as the population ages.
Jeremy Hunt commits £70 million funding over three and a half years for the Better Health Programme, a range of health initiatives that could improve the lives of up to 150 million people across 8 emerging economies.
Nurse. Researcher. Pioneer. Lesley Dibley gives a voice to a marginalised group and has changed the way doctors talk to patients with inflammatory bowel disease (IBD).
Here, Gerry Morrow discusses whether we will ever see AI fully replicate autonomous decision making and what the future role of AI in diagnostic medicine is.
Department of Health and Social Care announces improvements to the Accelerated Access Collaborative (AAC) that will put the most promising medicines, diagnostic tools and digital services through clinical development and regulatory processes faster.
Mynurva has commissioned a survey among more than 2,000 UK adults to uncover how much support is available for people in full-time work who suffer from mental health problems.
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
Goran Nenadic, from The University of Manchester and The Alan Turing Institute, argues for using patient information stored in routinely collected healthcare free-text data.
